Summer AAD Highlights

Our Dermatology Times reporter gleans takeaways from several experts who spoke at the summer meeting of the American Academy of Dermatology. In this program, our host Stefanie Stephens, talks with Drs. Dan Siegel, Marta VanBeek, Alison Ehrlich, and Galen Foulke about the problems with cloning medical record notes, why alternative payment models are an issue for dermatologists, proficiency in assessing skin concerns in transgender patients, and caring for patients with complex disease.

This program begins with Daniel Siegel, M.D., clinical professor of dermatology at the State University of New York in Brooklyn, speaking on the topic of cloning, tagging, and how to avoid orange pajamas. Dr. Siegel is a former president of the American Academy of Dermatology, and is currently an AAD advisor to the American Medical Association's RVS Update Committee or RUC. Dr. Siegel shares the main takeaways of his popular talk.

In segment two, Marta Van Beek, M.D., chief of staff of the University of Iowa Hospital and Clinic, and the C. William Hanke professor of dermatologic surgery in the department of dermatology talks about how to evaluate advanced alternative payment models or APMs and a payment approach that gives added incentive payments to provide high-quality and cost-efficient care. Dr. Van Beek is also secretary and treasurer of the American Academy of Dermatology.

In segment three, Alison Ehrlich, M.D., a private practioner at FoxHall Dermatology in Washington, D.C., and former founding chair and director of clinical research in the department of dermatology at the George Washington University, shares important takeaways from her Hands-On session: The Patient Encounter with the Transgender patient.

Finally, in segment four, Galen Foulke, M.D., shares insights from his talk on drug monitoring and prophylaxis. Dr. Foulke has a special interest in rheumatologic dermatology and he co-directed Penn State Health’s rheumatology dermatology integrated clinic for the last four years. His research focuses on autoimmune disease and stewardship and systemic therapies in dermatology.